Kumquat Biosciences

Innovating life-changing medicines for cancer patients

San Diego, United States · $70.0M raised

Employees
11–50
Business Model
B2B
Total Funding
$70.0M
Last Round
$50.0M Series AFeb 2021
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Kumquat Biosciences is a clinical-stage biotech company based in San Diego, California, founded by pioneers of the KRAS oncology field who previously co-founded Intellikine, Araxes/Wellspring Biosciences, and Kura Oncology. The company brings together drug discovery and clinical experts to translate breakthrough science into best-in-class therapeutics that provide sustainable benefits to cancer patients. Kumquat focuses on novel small-molecule inhibitors targeting the RAS pathway — including multiple KRAS mutant programs — and combines these targeted agents with immuno-oncology approaches to achieve durable anti-tumor responses. The company has entered major strategic collaborations with Bayer (Phase I KRAS G12D inhibitor) and Takeda (oral immuno-oncology candidate), reflecting strong validation of its pipeline by leading global pharma partners.

Summary

Kumquat Biosciences is a Biotech company based in San Diego, United States. It has raised $70.0M in total across 2 rounds, most recently a $50.0M Series A round in Feb 2021. Investors include Sequoia Capital, Codon Capital and EcoR1 Capital.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AFeb 2021
$50.0M

Sign up to see all 2 events

Funding: Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Kumquat Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/kumquat-biosciences"><img src="https://indexed.vc/api/badge/company/kumquat-biosciences" alt="Kumquat Biosciences on Indexed.vc" width="260" height="76" /></a>